1. AB0802 Endothelin1 receptor-antagonism (bosentan) reduces the progression of microvascular damage as assessed by nailfold capillaroscopy in systemic sclerosis patients: A 2 year survey. (23rd January 2014) Authors: Cutolo, M.; Vremis, L.; Zampogna, G.; Pizzorni, C.; Ferrone, C.; Ravera, F.; Cimmino, M.A.; Alessandri, E.; Seriolo, B.; Sulli, A. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗